HCKT(HCKT)
HCKT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $274M | $286M |
| Low | $274M | $283M |
| High | $275M | $288M |
| EBITDA Avg | $44M | $46M |
| Low | $44M | $46M |
| High | $44M | $47M |
| EBIT Avg | $41M | $42M |
| Low | $41M | $42M |
| High | $41M | $43M |
| Net Income Avg | $40M | $44M |
| Low | $39M | $43M |
| High | $40M | $44M |
| EPS Avg | $1.45 | $1.59 |
| Low | $1.44 | $1.57 |
| High | $1.46 | $1.61 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $69M | $70M | $69M | $71M | $71M | $72M |
| Low | $68M | $69M | $69M | $71M | $71M | $72M |
| High | $69M | $70M | $70M | $71M | $72M | $73M |
| EBITDA Avg | $11M | $11M | $11M | $11M | $12M | $12M |
| Low | $11M | $11M | $11M | $11M | $12M | $12M |
| High | $11M | $11M | $11M | $12M | $12M | $12M |
| EBIT Avg | $10M | $10M | $10M | $11M | $11M | $11M |
| Low | $10M | $10M | $10M | $10M | $11M | $11M |
| High | $10M | $10M | $10M | $11M | $11M | $11M |
| Net Income Avg | $9M | $10M | $9M | $10M | $10M | $11M |
| Low | $9M | $10M | $9M | $10M | $10M | $11M |
| High | $9M | $10M | $9M | $10M | $10M | $11M |
| EPS Avg | $0.37 | $0.39 | $0.36 | $0.39 | $0.40 | $0.42 |
| Low | $0.36 | $0.38 | $0.36 | $0.39 | $0.40 | $0.42 |
| High | $0.37 | $0.39 | $0.37 | $0.39 | $0.40 | $0.43 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |